Administering Monoclonal Antibody Therapy For Covid -19 - Dr. Sushila Kataria | Medanta
Medanta Medanta
292K subscribers
6,039 views
0

 Published On May 29, 2021

Monoclonal Antibody Therapy is a game-changing treatment for high-risk COVID19 individuals with mild to moderate symptoms.

Dr. Sushila Kataria (Senior Director, Internal Medicine, Medanta Gurugram) discusses how this therapy is administered while also detailing potential negative effects.

Visit Dr. Sushila Kataria’s Profile - https://www.medanta.org/doctors/dr-su...
To Book an Appointment - https://www.medantaeclinic.org/#!/login
Visit our Website - https://www.medanta.org/
Follow us for the latest updates:
Facebook:   / medanta  
Twitter:   / medanta  
Subscribe Now:    / medantathemedicity  
Learn more about Internal Medicine: https://www.medanta.org/internal-medi...

CHAPTERS
0:00 Monoclonal Antibody Therapy
0:19 Register UHID
0:59 Intravenous Infusion
1:39 Continue quarantine
2:04 Medanta For You

#MonoclonalAntibody #Monoclonal #Medanta #MedantaHospital #DrSushilaKataria

show more

Share/Embed